Regulation - Research, Actelion

Filter

Current filters:

ResearchActelion

Popular Filters

Actelion drops setipiprant, gets miglustat approval in Japan

04-04-2012

Switzerland-based Actelion Ltd (SIX: ATLN) announced says that it will re-direct its development efforts…

ActelionAsia-PacificBiotechnologyBrazavesInflammatory diseasesMiglustatRare diseasesRegulationResearchsetipiprantZavesca

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top